144 related articles for article (PubMed ID: 7358833)
1. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R
J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833
[No Abstract] [Full Text] [Related]
2. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
[No Abstract] [Full Text] [Related]
4. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins.
Falko JM; Schonfeld G; Witztum JL; Kolar JB; Salmon P
Metabolism; 1980 Jul; 29(7):654-61. PubMed ID: 7382829
[No Abstract] [Full Text] [Related]
5. Effects of diet on lipoprotein metabolism.
Goldberg AC; Schonfeld G
Annu Rev Nutr; 1985; 5():195-212. PubMed ID: 3896268
[No Abstract] [Full Text] [Related]
6. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
[TBL] [Abstract][Full Text] [Related]
8. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
9. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.
Ghiselli G; Schaefer EJ; Gascon P; Breser HB
Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720
[TBL] [Abstract][Full Text] [Related]
10. Plasma apoprotein changes after selective inhibition of hepatic triglyceride lipase in rat.
Kurz K; Grosser J; Schrecker O; Greten H
Atherosclerosis; 1984 Dec; 53(3):233-9. PubMed ID: 6084998
[TBL] [Abstract][Full Text] [Related]
11. Severe hypertriglyceridaemia associated with altered apolipoprotein C and E composition of the triglyceride-rich lipoproteins.
Stalenhoef AF; Demacker PN; Lutterman JA; Van't Laar A
Neth J Med; 1981; 24(4):145-51. PubMed ID: 7279085
[No Abstract] [Full Text] [Related]
12. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
Borghini I; James RW; Pometta D
Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
Utermann G
Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
[No Abstract] [Full Text] [Related]
14. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
15. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
Canzler H; Bojanovski D
Artery; 1980; 8(2):171-8. PubMed ID: 7458684
[TBL] [Abstract][Full Text] [Related]
16. Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.
Vessby B; Boberg J; Gustafsson IB; Karlström B; Lithell H; Ostlund-Linqvist AM
Atherosclerosis; 1980 Jan; 35(1):21-7. PubMed ID: 6768372
[TBL] [Abstract][Full Text] [Related]
17. Metabolic heterogeneity in very low-density lipoproteins.
Shepherd J; Packard CJ
Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
[No Abstract] [Full Text] [Related]
18. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
[TBL] [Abstract][Full Text] [Related]
19. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia.
Holmquist L
Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490
[TBL] [Abstract][Full Text] [Related]
20. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
Mahley RW; Angelin B
Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
